Artificial Intelligence
The market is expected to grow at a CAGR of 9.04% during the forecast period from 2021 to 2030
New York, July 29, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Urology Care Devices and Platforms Market: Focus on Product Type, Application, Indication, End User, and Regional Analysis” – https://www.reportlinker.com/p06124032/?utm_source=GNW
• Product- Devices (Conventional Devices and Advanced Devices) and Platforms
• Application- Treatment and Diagnosis and Monitoring
• Indication- Kidney Diseases, Urological Cancer and Benign Prostatic Hyperlapsia, Pelvic Organ Prolapse, and Other Diseases
• End User- Hospitals, Ambulatory Surgery Centers, and Clinics, Dialysis Centers, and Home Care Settings
Regional Segmentation
• North America – U.S., Canada
• Europe – Germany, U.K, France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, Argentina, and Rest-of-Latin-America
• Middle East and Africa – K.S.A., Israel, South Africa, and Rest-of-Middle East and Africa
Market Growth Drivers
• Rising Prevalence of Urological Disorders
• Rising Technology Integration in Urology Care
• Product Portfolio Expansion through Mergers and Acquisitions
Market Challenges
• High Upfront Cost of Devices
• Data Privacy Concerns
Market Opportunities
• Adoption of Telesurgery in Urology Care
• Emergence of Regional Companies in Global Urology Care Devices and Platforms Market
• Development of Remote Patient Monitoring Devices
Key Companies Profiled
Avenda Health, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group, Fresenius Medical Care AG & Co. KGaA, Intuitive Surgical, Inc., KARL STORZ SE & Co KG, Lucida Medical Ltd, Medtronic plc, Px HealthCare Ltd., Richard Wolf GmbH, Rocamed, Urologix, LLC.
How This Report Can Add Value
Who should buy this report?
• Technology/non-healthcare companies planning to enter the urology market through a platform, mobile application, or smart device
• Urological device manufacturers
• AI-enabled platform developers
• Imaging modalities companies (specifically for urology)
• Endoscope manufacturers
Key questions answered in the Global Urology Care Devices and Platforms Market Report
• How has COVID-19 impacted the adoption of urology care devices and platforms applications?
• What are the key regulations governing the urology care devices and platforms market in key regions?
• What are the technological developments projected to have the maximum influence on the global urology care devices and platforms market?
• Who are the leading players holding significant dominance in the global urology care devices and platforms market currently?
• What are the drivers and restraints for the global urology care devices and platforms market?
• Which region has the highest growth rate in the urology care devices and platform market?
• Who are the key end-users of the global urology care devices and platform market?
• Which are the emerging companies in the global urology care devices and platforms market?
Global Urology Care Devices and Platforms Market Overview
The scope of the global urology care devices and platforms market involves conventional and advanced devices as well as platforms that are used in urological disease management.The conventional devices include dialysis devices, endoscopy and urology-specific imaging devices, lasers and lithotripsy devices, endoscopy fluid management systems, insufflators, and urodynamic systems.
Furthermore, consumables such as guidewires and catheters, stents, biopsy devices, and other disposable consumables such as drainage bags, sheaths, and stone retrieval baskets are also categorized as conventional devices. The advanced devices include technology-enabled devices such as neurostimulators, robotic systems, and other emerging technology devices used for urology disorder management.
The global urology care devices and platforms market comprises of various key medical device companies and emerging companies. The major medical device companies operating in the market include Baxter International Inc., Olympus Corporation, Boston Scientific Corporation, Becton, Dickinson and Company, and Medtronic plc.
However, owing to the rising technology penetration and demand for minimally invasive procedures, various novel companies such as Axonics Modulation Technologies, Inc., Micron Medical Corporation, and robotic system companies such as Intuitive Surgical, Inc. have also entered the market and are offering advanced devices such as neurostimulators for urological treatment. Additionally, owing to the rising demand for remote patient monitoring and integration of digital solutions, emerging companies such as CareLogiQ Corp, Renalytix AI plc, and Healthy.io Ltd have entered the market and are projected to witness significant growth during the forecast period 2021-2030.
The pipeline of global urology care devices and platforms market primarily comprises advanced devices and platforms.Various companies such as Implantica AG, Micron Medical, Lucida Medical, and Neuspera Medical have products in the pipeline that are anticipated to be commercialized by the end of 2030.
The launch of these products is projected to propel technology integration in the urology care landscape.
The factors driving growth include rising prevalence of urological disorders, rising technology integration, and product portfolio expansion through mergers and acquisitions.The restraints to the global urology care devices and platforms market include high upfront cost of the devices and data privacy concerns.
The opportunities for the global urology care devices and platforms market lie in the adoption of telesurgery in urological practices, emergence of regional companies, and development of remote patient monitoring devices.
Key technology trends such as the switch from open procedures to minimally invasive procedures, inclusion of telemedicine in urology practices, remote patient monitoring devices, and integration of artificial intelligence (AI) for improved patient assessment are anticipated to influence the global urology care devices and platforms market.AI has been integrated into various healthcare applications for improved data analytics.
AI inclusion in diagnosis, medical imaging, data collection, result interpretation, and treatment planning has improved physician’s decision-making quality.
The global urology care devices and platforms market has witnessed significant technology integration in the past few years.There has been significant design- and product-level innovations in the market.
For instance, more than 5,100 patents have been filed from January 2015 -June 2021, with the highest number of filings in 2019 (1,792 patents).
During January 2018-June 2021, the global urology care devices and platforms market witnessed 50 key developments.Regulatory and legal activities were the most actively employed strategies, followed by mergers and acquisitions.
The key companies that received regulatory approvals between January 2018-June 2021 included Advanced MedTech Holdings Pte. Ltd., Baxter International Inc., Medtronic plc, Teleflex Incorporated, Axonics Modulation Technologies, Aveda Health, and Lucida Medical Ltd. Similarly, several partnerships took place between January 2018-June 2021. The aim of strategic partnerships includes new product development, strengthening of distribution network, and business expansion.
New product launches are one of the primary strategies adopted by new companies to enter in the global urology care devices and platforms market.Companies have also been working on upgrades for their existing products.
Between January 2018-June 2021, several new products were launched in the global urology care devices and platforms market.Companies such as Advanced MedTech Holdings Pte.
Ltd., B. Braun Melsungen AG, Teleflex Incorporated, and Stryker Corporation launched their products in the mentioned period. Furthermore, funding activities are critical for the entry and operation of start-ups in the global urology care devices and platforms market. Advanced MedTech Holdings is one of the prominent investors in the global urology care devices and platforms market that has regularly invested in various start-ups.
Two business models, namely, business to customer (B2C) and distributor network, are operational in the global urology care devices and platforms market.The device manufacturers often employ both the business models for ensuring a prominent local and global presence.
Furthermore, owing to the emergence of platforms companies enabling remote patient monitoring and improved imaging analytics, software-as-a-service (SaaS) is anticipated to become one of the prominent business models in the market.
The global urology care devices and platforms market report highlights that the market was valued at $13.61 billion in 2019 and is expected to reach $33.64 billion by the end of 2030. The market is expected to grow at a CAGR of 9.04% during the forecast period from 2021 to 2030.
Global Urology Care Devices and Platforms Market Drivers
The factors driving growth include rising prevalence of urological disorders, rising technology integration, and product portfolio expansion through mergers and acquisitions.The high susceptibility of diabetic patients to urinary tract infections (UTI) is a major factor for growing urological disorder cases.
Thus, with the rise in diabetic patients across the world, UTIs are becoming widespread.
There has been a shift in preference by urologists toward single use endoscopes as compared to reusables.This is due to the risk of contamination associated with reusable endoscopes.
Additionally, the usage of minimally invasive procedures as treatment for lower urinary tract symptoms (LUTS) has drastically increased since 2013.
Lastly, there have also been several key mergers and acquisitions in the field of urology that have driven the global urology care devices and platforms market. This assists the companies in gaining access to newer technologies and strengthening their product offering.
Global Urology Care Devices and Platforms Market Challenges
The restraints to the global urology care devices and platforms market include high upfront cost of the devices and data privacy concerns.
While singe use instruments such as endoscopes have benefits that outweigh those of reusable devices, a major limitation encountered with single use instruments is their high upfront cost which puts pressure on the global urology care devices and platforms market.This causes an increase in hospital expenditure which subsequently leads to higher treatment costs.
As a result, healthcare becomes both less affordable and accessible.
Data breaches are a huge source of concern for healthcare organizations as such incidents can cause legal issues and increase the risk of the practice being shut down. Such cases negatively influence the global urology care devices and platforms market and thus, pose a hindrance to the growth of the market.
Global Urology Care Devices and Platforms Market Opportunities
The opportunities for the global urology care devices and platforms market lie in the adoption of telesurgery in urological practices, emergence of regional companies, and development of remote patient monitoring devices.
Under the realm of telemedicine, telesurgery is one of the most challenging yet promising areas.Technological advancement and the development of high-speed internet with a wide bandwidth have positively influenced the field of telesurgery and telesurgical monitoring.
While telesurgery holds potential in the field of global urology care devices and platforms market, it is advancement in telecommunication technologies that will allow telesurgery’s applications in the field of education as well as assistance in urological procedures.
With more companies venturing into developing products with novel technologies, there is increased competition among the players in the global urology care devices and platforms market.While the major players in the global urology care devices and platforms market hold a larger market share, newer start-ups are focusing on entering the market by launching products that integrate concepts like artificial intelligence AI and machine learning (ML) into their devices.
This gives them an edge over the already existing products.
There are a number of remote patient monitoring devices in the global urology care devices and platforms market currently, such as CarePath by I-O Urology, CarelogiQ by CareLogiQ Corp, and KidneyIntelX by Renalytix AI plc, s. The demand for the devices is projected to grow in the future owing to the growing preference among patients and physicians, continuous patient monitoring, improvement in the decision-making process, and accelerated prognosis and treatment planning.
Impact of COVID-19 on Global Urology Care Devices and Platforms Market
In the short term, i.e., 2-4 years from 2020, COVID-19 would have a high impact on the global urology care devices and platforms market. The demand for remote patient monitoring devices is anticipated to be highest during this timeframe.
5-10 years from 2020, the resumption of elective surgeries and normalization of the supply chain would be the key factors for market recovery. Finally, in the long term, i.e., 8-12 years from 2020, the supply chain, production, and installation of conventional and advanced urology care devices are anticipated to be normalized.
Market Segmentation
Global Urology Care Devices and Platforms Market (by Product)
The global urology care devices and platforms market (by product) is segmented into conventional and advanced devices as well as platforms.The conventional devices include dialysis devices, endoscopy and urology-specific imaging devices, lasers and lithotripsy devices, endoscopy fluid management systems, insufflators, and urodynamic systems.
Furthermore, consumables such as guidewires and catheters, stents, biopsy devices, and other disposable consumables such as drainage bags, sheaths, and stone retrieval baskets are also categorized as conventional devices. The advanced devices include technology enabled devices such as neurostimulators, robotic systems, and other emerging technology devices used for urology disorder management.
Global Urology Care Devices and Platforms Market (by Application)
The global urology care devices and platforms market (by application) is segmented into treatment, and diagnostics and monitoring.In terms of opportunities, the global urology care devices and platforms market holds significant growth potential for the diagnosis and monitoring segment.
The shifting preference from at-clinic to at-home diagnostic and monitoring services presents abundant opportunities for the segment.
Global Urology Care Devices and Platforms Market (by End User)
The global urology care devices and platforms market (by end user) is segmented into hospitals, ambulatory surgery centers (ASCs), and clinics, dialysis centers, and home care settings.In terms of end user, the global urology care devices and platforms market holds significant growth opportunities in ASCs and homecare settings segment.
This is owing to the growing prevalence of urological conditions, rise in adoption of remote patient monitoring devices, and rising demand for homecare. However, the predominance of hospitals and clinics is anticipated to continue during the forecast period 2021- 2030.
Global Urology Care Devices and Platforms Market (by Indication)
The global urology care devices and platforms market (by indication) is segmented into kidney diseases, urological cancer and benign prostatic hyperplasia, pelvic organ prolapse, and other diseases.The global urology care devices and platforms market holds significant potential in urological disorders such as kidney diseases, benign prostatic hyperplasia (BPH), bladder cancer, prostate cancer, and urinary incontinence.
The rising prevalence of kidney diseases is attributed to factors such as a sedentary lifestyle, an unhealthy diet, and genetics. There are several conventional as well as advanced devices and platforms indicated to diagnose, treat, and monitor these urological disorders.
Global Urology Care Devices and Platforms Market (by Region)
The different regions covered under the global urology care devices and platforms market report include North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America dominated the global urology care devices and platforms market in 2019 and is anticipated to uphold its dominance throughout the forecast period.The growth in the market is majorly driven by the increasing research and development activities and large-scale adoption of global urology care devices and platforms.
Also, the ongoing trend for digital transformation through the development of platforms and mobile applications is putting a significant impact on the market growth.
Key Market Players and Competition Synopsis
Avenda Health, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group, Fresenius Medical Care AG & Co. KGaA, Intuitive Surgical, Inc., KARL STORZ SE & Co KG, Lucida Medical Ltd, Medtronic plc, Px HealthCare Ltd., Richard Wolf GmbH, Rocamed, and Urologix, LLC.
The global urology care devices and platforms market has witnessed several strategic and technological developments in the past few years, undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are regulatory and legal activities, partnerships and alliances, new offerings, mergers and acquisitions, expansion activities, and funding activities.
Countries Covered
• North America
• U.S.
• Canada
• Europe
• Germany
• Italy
• France
• Spain
• U.K.
• Rest-of-Europe
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia and New Zealand
• Rest-of-Asia-Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest-of-Latin America
• Middle East and Africa
• K.S.A.
• Israel
• South Africa
• Rest-of-Middle East and Africa (Rest-of-MEA)
Read the full report: https://www.reportlinker.com/p06124032/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Artificial Intelligence
Aidoc and Integral Diagnostics (IDX) Expand AI Partnership in Australia and New Zealand
Aidoc’s AI technology enhances radiology services at IDX, significantly improving patient care and service and well-placed to support the upcoming National Lung Cancer Screening Program.
MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ — Aidoc, a global pioneer in clinical AI solutions, today announced the expansion of its partnership with Integral Diagnostics (IDX), the leading provider of AI-driven medical imaging services, across Australia and New Zealand. This enhanced collaboration, which started four years ago, leverages Aidoc’s award-winning aiOS™ platform to alert radiologists and care teams to suspected and unsuspected critical findings in medical images, prioritising abnormal findings and improving the quality and timeliness of patient care across the region.
Aidoc’s AI technology has firmly positioned IDX as the market leader in AI-driven medical imaging in Australia and New Zealand, with its aiOS™ platform automatically flagging critical pathologies, including brain aneurysms, pulmonary embolisms, stroke, and brain bleeds.
Since 2019, Aidoc has processed over 600,000 cases across IDX’s entire network, including its partner facilities and hospitals. By augmenting radiologists’ workflows, it enables prioritization of life-threatening cases when these are detected by the AI, leading to improved care and efficiency, and ultimately facilitating faster, life-saving treatments for patients.
Looking ahead, significant advancements are on the horizon. Starting July 2025, the Australian Government will fund the National Lung Cancer Screening Programme (NLCSP), a crucial step in early detection of lung cancer. IDX is currently trialling a new algorithm within Aidoc’s aiOS™ platform designed to notify radiologists of lung nodules and measure them accurately, enabling earlier and appropriate intervention for lung cancer.
“Aidoc’s AI has significantly improved patient care and service. We’re keen to test and use their Chest CT AI algorithms to automate our reviews in the National Lung Cancer Screening Programme to enable us to detect disease earlier, more accurately and more efficiently”, said Dr. Ian Kadish, CEO and Managing Director at Integral Diagnostics.
Already widely adopted across the United States and Europe, Aidoc’s AI aiOS™ platform analyses over 3 million patients monthly and is backed by more than 150 published papers and abstracts. These demonstrate its proven ability to reduce costs, improve patient outcomes and increase efficiency, making it a leader in AI-powered radiology.
This partnership between Aidoc and IDX represents not just a technological leap forward but a shift in how radiology will evolve in the years to come. With AI seamlessly integrated into workflows, healthcare providers can focus on delivering the highest level of patient care. Aidoc and IDX are shaping the future of medical imaging, with early detection, improved patient outcomes and improved healthcare efficiency.
“Our partnership with Integral Diagnostics underscores our commitment to driving better health outcomes,” said Rotem Geslevich, Senior Director of Business Development at Aidoc. “As the Lung Cancer Screening initiative approaches, we are excited to play a pivotal role in saving lives.”
Both Aidoc and Integral Diagnostics will be featured at the RANZCR conference in Perth from 17-19 October 2024. Attendees can learn more about the evolving role of AI in radiology and its positive impact on patient care across Australia and New Zealand.
About Aidoc
Aidoc is a pioneering force in clinical AI. Aidoc focuses on aiding and empowering healthcare teams to optimize patient treatment, which results in improved economic value and clinical outcomes. Built on Aidoc’s proprietary aiOS™, Aidoc analyses and aggregates medical data to enable care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Used in more than 1,000 medical centers worldwide, Aidoc has the most TGA clearances in clinical AI and its AI-based solutions cover 75 percent of patient populations, enabling physicians to make informed decisions based on real-time data.
Visit www.Aidoc.com to see how we are connecting all points of care with always-on AI.
About IDX
Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand. IDX employs some of Australasia’s leading radiologists and diagnostic imaging specialists in a unique medical leadership model that ensures quality patient care, service and access. Good medicine is good business. For more information, please visit www.integraldiagnostics.com.au/.
Logo: https://mma.prnewswire.com/media/2015772/4967383/Aidoc_Always_On_AI_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/aidoc-and-integral-diagnostics-idx-expand-ai-partnership-in-australia-and-new-zealand-302275816.html
MANILA, Philippines, Oct. 15, 2024 /PRNewswire/ — Arcadis, the leading global design and consultancy firm for natural and built assets, is proud to announce its participation at the upcoming QS Summit 2024 as Gold Sponsor. It is the biggest gathering of Filipino quantity surveyors in the country, organized by the Philippine Institute of Certified Quantity Surveyors (PICQS), Inc.
The summit, themed “The Evolving Role of Quantity Surveyors in Shaping a Smart and Greener Future”, will take place on 19 October at AIM Conference Center, Makati City, Philippines.
This year the event will explore how quantity surveyors and their allied professions practice their roles in terms of sustainable cost and project management, utilization of digital solutions and enhanced sustainability, with less risk to the environment. The event provides a valuable platform for industry leaders to discuss critical trends and advancements shaping the future of the profession.
With over thirty years’ experience in quantity surveying and cost and commercial management in the Philippines, Arcadis has established itself as one of the leading consultants in the country. As forerunners in the industry, Arcadis has been instrumental in helping shape the Philippine construction landscape, contributing to the development of iconic, game-changing and sustainable projects since the 1990s. Arcadis’ sponsorship of the QS Summit 2024 underscores its commitment to supporting the professional growth of Filipino quantity surveyors, enabling them to meet the demands of a rapidly evolving industry and contribute to a sustainable future.
In addition to sponsorship, Arcadis will be speaking at the Summit alongside other industry practitioners. Country Director Darneil Perez will join a panel discussion titled “Digital Transformation (AI and Digital Technology Adoption) – Where are We Now and Where are We Heading?”. Together with consultants, developers and contractors, Darneil will offer valuable perspectives on the challenges and opportunities facing the Philippine construction industry in terms of technological advancements, global trends and national development goals.
PICQS, Inc. is an all-Filipino organization comprised of members of the Royal Institution of Chartered Surveyors (RICS); members of the Australian Institute of Quantity Surveyors (AIQS); student and trainee members of RICS; chartered members of internationally recognized QS professional bodies; QS-trained engineers working toward their QS Study; Assessment of Professional Competence (APC) and Assessment of Technical Competence (ATC) toward chartered membership.
About Arcadis
Logo – https://mma.prnewswire.com/media/1838726/Arcadis_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/arcadis-supports-picqs-qs-summit-2024-in-manila-as-gold-sponsor-302275397.html
Artificial Intelligence
Glancing into Tomorrow at GITEX: e& UAE’S Vision for a Smarter, AI-powered Future
DUBAI, UAE, Oct. 14, 2024 /PRNewswire/ — As e& UAE prepares to make an impact at GITEX Global, the company’s momentum is undeniable. Fresh off the heels of being crowned ‘World’s Fastest 5G Network’ by Ookla, e& UAE is poised to showcase the cutting-edge innovations stemming from its state-of-the-art telco core.
e& UAE serves 5G to 12 million active users every day bringing to the forefront of global connectivity. “High-speed networks are crucial for connecting the dots between AI components, including transferring data and accessing cloud-based resources,” says Masood. “In essence, AI is a product of a sophisticated infrastructure that combines hardware, software, and networking to enable the development and deployment of intelligent systems,” Masood says.
For e& UAE, this means continually embracing AI as a key component of its innovation strategy. The company has a successful history of implementing AI solutions to drive productivity and enhance customer experiences, and, as Masood puts it, “AI is where we see the real potential for transformation.”
It’s with this vision in mind that e& UAE plans to make its mark at GITEX, showcasing its latest AI innovations and demonstrating its leadership in the digital landscape.
More than a telco: e& UAE’s digital leap
“AI is embedded across our operations, enabling smarter, faster decision-making and driving new efficiencies in business and customer service,” he says. e& UAE was a pioneer in adopting AI internally, but its true impact lies in delivering exceptional digital experiences to customers. A prime example is EASE, the world’s first autonomous telecom retail experience, launched at GITEX last year. Since then, e& UAE has rapidly expanded the reach and capabilities of this innovative concept, demonstrating its commitment to leveraging AI for customer-centric solutions.
The company is actively building its reputation as a digital leader, offering cutting-edge connectivity solutions powered by 5G and AI and IoT integrations. This strategic shift is at the heart of e& UAE’s participation at GITEX, where the company will showcase its innovative digital offerings and vision for the future.
GITEX spotlight
“We’re thrilled to be part of GITEX, an exciting showcase of the future where the world’s greatest minds come together to envision and shape the technology of a better tomorrow,” Masood says.
In addition to the latest smart home solutions and drone technology, its showcase will include advanced applications in AI, augmented reality, and 5G technology, reflecting its commitment to digital transformation. One of the standout features will be the Hologram Customer Service Avatar, which aims to provide an interactive customer experience. This avatar will utilise ultra-HD, intelligent capabilities to facilitate real-time interactions, allowing users to engage with services in a more immersive manner. The integration of 5G New Calling technology will further enhance user experience by offering visualised voice calling, real-time translation, and multimedia content during calls.
Continuing the tradition of announcing 5G milestones at previous GITEX events, e& UAE announced network speed upgrades including the fastest aggregated 5G-Advanced speed of 62Gbps. Demonstrating its commitment to 5G leadership, e& UAE will also highlight its achievement as the largest 5G-Advanced commercial network in the MENA region, with over 1,000 operational sites. This milestone marks the dawn of the 10G era, delivering unparalleled speeds and ultra-low latency that will redefine digital experiences. At GITEX, it will not only showcase its impressive technological advancements but also unveil strategic partnerships that align with its vision for a digital future. Building upon the success of its 5G private network deployment in the oil and gas sector with ADNOC, the company is now expanding its reach in more industries.
“The success of AI, IoT, and 5G depends on building an ecosystem of innovation. That means working closely with tech giants, startups, and government entities to ensure we’re building the right solutions for the future,” says Masood.
Making networks AI-ready
At the heart of e& UAE’s mission to pioneer the digital frontier in the UAE lies a firm commitment to high-speed connectivity. For example, 50G-PON, the next generation of high-speed connectivity, promises to revolutionise internet connectivity, delivering unprecedented capacity and considerably speeding things up for consumers and businesses.
“Our strategy is rooted in a profound belief that we can achieve more for the people and communities we serve—drive more growth, create more opportunities, and have a greater impact—infused with a passion for excellence. As we evolve beyond traditional telecom, we are enhancing our services and tailoring our offerings to meet the diverse needs of our customers.
The UAE’s global leadership in broadband and mobile speeds, as recognised by Ookla, is significantly attributed to the contributions of e& UAE. “We are part of the UAE fabric, and we stand with the country, helping to build a stronger, more connected society,” Masood concludes.
Contact details: Nancy Sudheer, Senior Manager at e&, [email protected]
Photo – https://mma.prnewswire.com/media/2529931/e_GITEX_2024.jpgPhoto – https://mma.prnewswire.com/media/2529932/stand_GITEX.jpg
View original content:https://www.prnewswire.co.uk/news-releases/glancing-into-tomorrow-at-gitex-e-uaes-vision-for-a-smarter-ai-powered-future-302275312.html
-
Artificial Intelligence4 days agoDun & Bradstreet Global Business Optimism Insights Report Shows Quarterly Increase
-
Artificial Intelligence4 days agoAutomation.com & Hikvision white paper: how AIoT technologies drive manufacturing digitalization
-
Artificial Intelligence6 days agoThundercomm Launches RUBIK Pi on Qualcomm Platforms
-
Uncategorized7 days agoOver 2000 Companies Hire NxtWave Learners, Addressing the Talent Gap in India’s Booming IT Industry
-
Artificial Intelligence7 days agoPrecisely Announces Breakthrough in Data Enrichment with New Data Graph API
-
Artificial Intelligence6 days agoHigh tech specs and adapted World Cup pitch sensors awarded share of £1.5m as finalists in Longitude Prize on Dementia
-
Artificial Intelligence4 days agoACCENTURE CHAIR & CEO JULIE SWEET TO DELIVER KEYNOTE AT CES 2025
-
Artificial Intelligence6 days agoACT³ to Embrace the GIGA and AI eras
